Feedback

Eosinophils, Basophils, and Neutrophils in Bullous Pemphigoid

ORCID
0009-0008-3822-6079
Affiliation
Division of Experimental Allergy and Immunodermatology, School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, 26129 Oldenburg, Germany
Limberg, Maren M.;
ORCID
0000-0002-4553-7464
Affiliation
Division of Experimental Allergy and Immunodermatology, School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, 26129 Oldenburg, Germany
Weihrauch, Tobias;
ORCID
0000-0003-4091-4176
Affiliation
Division of Experimental Allergy and Immunodermatology, School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, 26129 Oldenburg, Germany
Gray, Natalie;
ORCID
0000-0002-3248-2425
Affiliation
Department of Dermatology, University of Lübeck, 23562 Lübeck, Germany
Ernst, Nancy;
ORCID
0000-0002-4595-8226
Affiliation
Division of Allergy, Departments of Dermatology and Biomedicine, University Hospital Basel and University of Basel, 4031 Basel, Switzerland
Hartmann, Karin;
ORCID
0000-0002-9573-4714
Affiliation
Division of Experimental Allergy and Immunodermatology, School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg, 26129 Oldenburg, Germany
Raap, Ulrike

Bullous pemphigoid (BP) is an autoimmune blistering skin disease, of which the incidence has increased in recent years. BP is characterized by circulating IgG and IgE autoantibodies against the hemidesmosomal proteins BP180 and BP230. Although autoantibodies trigger inflammatory cascades that lead to blister formation, effector cells and cell-mediated autoimmunity must also be considered as important factors in the pathogenesis of BP. The aim of this review is to outline the current knowledge on the role of eosinophils, basophils, and neutrophils in BP.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: © 2023 by the authors.

Use and reproduction: